Abstract
Enteric-coated guar gum microspheres of ornidazole aimed for colon drug delivery have been developed. The influence of core to coat ratio was investigated upon the encapsulation efficiency, swelling, weight loss and drug release behavior. The SEM was used to characterize the surface of these microspheres. Drug–polymer interactions were studied by differential scanning calorimetry and X-ray diffractometry. Enteric coating with Eudragit® S100 enabled maintenance of microspheres integrity until its expected arrival to colon. The in vitro drug release was investigated using USP dissolution rate test paddle type apparatus in different simulated mediums. Only 10 % of drug was release after 5 h while after 8 h (in PBS pH 7.5) a significant increase in percent cumulative drug release (85 %) was observed. In medium containing rat cecal content (pH 7.0) i.e. the amount of the drug released from the formulation was found to be 68 % and ~ 78.3 % with 2 % and 4% w/v cecal matter. Drug release in presence of culture of Bacteriodes ovatus was found to be 77 %. Ornidazole release kinetics corresponds best to zero order model and drug release mechanism was diffusion and swelling controlled. The significance of differences was evaluated by analysis of variance (ANOVA). Differences were considered statistically significant at P < 0.05.
Keywords: Enteric coating, ornidazole, guar gum, eudragit® S100, microspheres, rat cecal contents, bacterial culture, DSC, XRD
Current Nanoscience
Title:Enteric Coated Guar Gum Microspheres of Ornidazole for Colonic Delivery
Volume: 8 Issue: 4
Author(s): Raj Kumar Shukla, Suman Ramteke, Piyush Trivedi and Akanksha Tiwari
Affiliation:
Keywords: Enteric coating, ornidazole, guar gum, eudragit® S100, microspheres, rat cecal contents, bacterial culture, DSC, XRD
Abstract: Enteric-coated guar gum microspheres of ornidazole aimed for colon drug delivery have been developed. The influence of core to coat ratio was investigated upon the encapsulation efficiency, swelling, weight loss and drug release behavior. The SEM was used to characterize the surface of these microspheres. Drug–polymer interactions were studied by differential scanning calorimetry and X-ray diffractometry. Enteric coating with Eudragit® S100 enabled maintenance of microspheres integrity until its expected arrival to colon. The in vitro drug release was investigated using USP dissolution rate test paddle type apparatus in different simulated mediums. Only 10 % of drug was release after 5 h while after 8 h (in PBS pH 7.5) a significant increase in percent cumulative drug release (85 %) was observed. In medium containing rat cecal content (pH 7.0) i.e. the amount of the drug released from the formulation was found to be 68 % and ~ 78.3 % with 2 % and 4% w/v cecal matter. Drug release in presence of culture of Bacteriodes ovatus was found to be 77 %. Ornidazole release kinetics corresponds best to zero order model and drug release mechanism was diffusion and swelling controlled. The significance of differences was evaluated by analysis of variance (ANOVA). Differences were considered statistically significant at P < 0.05.
Export Options
About this article
Cite this article as:
Kumar Shukla Raj, Ramteke Suman, Trivedi Piyush and Tiwari Akanksha, Enteric Coated Guar Gum Microspheres of Ornidazole for Colonic Delivery, Current Nanoscience 2012; 8 (4) . https://dx.doi.org/10.2174/157341312801784186
DOI https://dx.doi.org/10.2174/157341312801784186 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmaceutical Interventions for Frailty and Sarcopenia
Current Pharmaceutical Design Targeted Drug Delivery Using Tuftsin-bearing Liposomes: Implications in the Treatment of Infectious Diseases and Tumors
Current Drug Targets Lipid-Based Vectors for Therapeutic mRNA-Based Anti-Cancer Vaccines
Current Pharmaceutical Design Discovery of New Biomarkers of Cancer Using Proteomics Technology
Current Cancer Therapy Reviews Head and Neck Cancer Treatments through Chemotherapy to Magnetic Systems: Perspectives and Challenges
Current Radiopharmaceuticals Interactome Analysis of the Differentially Expressed Proteins in Uterine Leiomyoma
Anti-Cancer Agents in Medicinal Chemistry Predicting Chemotherapy Sensitivity Profiles for Breast Cancer Cell Lines with and Without Stem Cell-Like Features
Current Signal Transduction Therapy Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery TEM8 Targeted Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry The Implications of Sortilin/Vps10p Domain Receptors in Neurological and Human Diseases
CNS & Neurological Disorders - Drug Targets Synthesis and Biological Evaluation of 1,5-Naphthyridines as Topoisomerase I Inhibitors. A New Family of Antiproliferative Agents
Current Topics in Medicinal Chemistry CXCR7 Participates in CXCL12-mediated Cell Cycle and Proliferation Regulation in Mouse Neural Progenitor Cells
Current Molecular Medicine Damage and Recovery of the Bone Marrow Microenvironment Induced by Cancer Chemotherapy – Potential Regulatory Role of Chemokine CXCL12/Receptor CXCR4 Signalling
Current Molecular Medicine Role of MMPs in Metastatic Dissemination: Implications for Therapeutic Advances
Current Pharmaceutical Biotechnology Immunotherapy with Tumor Vaccines for the Treatment of Malignant Gliomas
Current Drug Discovery Technologies Drug Repurposing Approaches: Existing Leads for Novel Threats and Drug Targets
Current Protein & Peptide Science The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue
CNS & Neurological Disorders - Drug Targets Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutations in the Occurrence and Treatment of Pancreatic Cancer
Current Topics in Medicinal Chemistry The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
Current Pharmaceutical Design Potential Anticancer Agents. I. Synthesis of Isoxazole Moiety Containing Quinazoline Derivatives and Preliminarily in vitro Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry